Hormonal contraceptives taken by adolescents may affect risk assessment behavior
Hormonal contraceptives taken by adolescents may influence development of the brain in a way that alters the recognition of risks, a new study in rats suggests.
Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest
Low levels of Vitamin D have been shown to be associated with a higher risk of having a cardiac event, like a heart attack or stroke.
Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk
An experimental anti-clotting medication, abelacimab, significantly reduced bleeding among people with atrial fibrillation (or AFib) who were at risk of stroke, according to results of the AZALEA-TIMI 71 trial, presented…
Study shows long-term cardiovascular benefits of tight blood pressure control after pregnancy
Women with high blood pressure during pregnancy had long-term blood pressure and cardiac benefits if their blood pressure was carefully controlled for the first few weeks after having a baby,…
New drug zilebesiran effectively lowers blood pressure for six months, study finds
A single injection of the experimental medication zilebesiran was safe and effective in reducing systolic blood pressure in people with mild-to-moderate high blood pressure for up to six months, as…
Shortening sleep time increases diabetes risk in women
A new study in women found that shortening sleep by just 90 minutes for a few weeks increased insulin resistance, a risk factor for type 2 diabetes.
Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia
A National Institutes of Health-supported study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference…
ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development
ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract.
NanoSyrinx appoints Anthony Johnson as Non-Executive Director
Appointment of Big Pharma executive strengthens leadership team to drive ambitious growth strategy.
BioEcho introduces EchoLUTION™ FFPE RNA Kit for superior RNA extraction from FFPE tissues
A leading provider of innovative molecular biology solutions, announces the launch of its EchoLUTION FFPE RNA Kit.